Tobacco smoking is a grave problem in the United States. The death rate involving Americans who smoke is three times more than those who have never smoked. Tobacco use is the leading preventable cause of death in the country, according to the Centers for Disease Control and Prevention (CDC). In fact, people are addicted not only to tobacco, but many other substances.
The pervasiveness of addictive habit led the Substance Abuse and Mental Health Services Administration (SAMHSA) to commemorate September 2016 as the National Recovery Month. Through this initiative, the SAMHSA aims to educate and inform people about the adverse impact of substance use disorders on mental health.
While a lot is said about men and women possessing similar or differing levels of potential depending upon circumstances, a study analyzing smoking cessation tendencies among adults revealed that some capabilities are indeed gender biased.
A recent study by the Yale University and the Yeshiva University attempted to find if gender needs should be taken into consideration during selection of pharmacological treatment options to curb smoking.
In the study, titled “Sex Differences in Smoking Cessation Pharmacotherapy Comparative Efficacy: A Network Meta-analysis,” the researchers tried to determine and compare efficiency of transdermal nicotine (TN), varenicline, and sustained release (SR) bupropion in curbing smoking in male and female.
The study, published online in the journal Nicotine & Tobacco Research in May 2016, analyzed details of 14,000 cigarette smokers who had participated in 28 clinical trials for nicotine patch, varenicline and bupropion. An analysis of the results revealed significant differences in the abilities of different medicines prescribed to enable smokers get rid of their smoking habit.
The scientists found that women who were prescribed varenicline during the study were in greater likelihood of quitting smoking when compared to male participants. Also, men showed relatively lesser likelihood of quitting smoking when advised varenicline, bupropion or nicotine patch.
A detailed examination of the observations also indicated that medications helped both male and female smokers get rid of smoking when contrasted with those prescribed no medicines. While the details pinpointed that medicines helped smokers quit, women showed greater proclivity to give up tobacco addiction.
Stressing on the findings, co-author Philip Smith, assistant medical professor at the City College of New York’s Sophie Davis Biomedical Education/CUNY School of Medicine, said, “Before our study, research had shown that among the choices for medications for smokers who wanted to quit, varenicline was the clear winner when it came to promoting quitting. Our study shows this is clearly the case for women. The story seems less clear among men, who showed less of a difference when taking any of the three medications.”
It is difficult to get rid of addictive habit and the same applies to tobacco dependence. Teenagers and young adults initially smoke for fun, but are unable to get rid of it due to the addictive properties of nicotine. According to the CDC, cigarette smoking results in nearly 480,000 premature deaths and more than $300 billion in direct health care expenditure and productivity loss every year.
Though tobacco smokers are advised medications to get rid of their dependence, the findings help understand the effect of varenicline as compared to others for the same. If you or your loved one is addicted to nicotine or any other substance, you may get in touch with the 24/7 Recovery Helpline for information on the best drug rehab centers in America. Call at our 24/7 helpline number 855-441-4405 or chat online for expert advice on various drug abuse treatment centers.